View CNVs/SVs
View by Evidence Type: All (
CNVs Only Present In Patients
de novo CNVs
Overlapping/Recurrent CNVs
CNVs Overlapping With ACRD
CNVs Not Present In Control
Significant Enriched CNVs
Others
All
)
View by Chromosome:All ( 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 X Y All )
Notes: ACRD: Autism Chromosome Rearrangement Database
CNV Name | Chr | Band | Gain/Loss | Number of CNVs | Evidence Type | Reference | |
---|---|---|---|---|---|---|---|
Case | Control | ||||||
AutCNV0005932 | 20 | 20q11.21 | gain | - | - | de novo CNVs; | Brandler WM, 2018 |
AutCNV0005933 | 20 | 20q13.33 | gain | - | - | de novo CNVs; | Brandler WM, 2018 |
AutCNV0005934 | 22 | 22q12.3 | loss | - | - | de novo CNVs; | Brandler WM, 2018 |
AutCNV0005935 | 22 | 22q13.33 | loss | - | - | de novo CNVs; | Brandler WM, 2018 |
AutCNV0005936 | 22 | 22q13.33 | loss | - | - | de novo CNVs; | Brandler WM, 2018 |
AutCNV0005937 | X | Xp21.1 | loss | - | - | de novo CNVs; | Brandler WM, 2018 |
AutCNV0005938 | X | Xp11.22 | - | - | - | de novo CNVs; | Brandler WM, 2018 |
AutCNV0005939 | X | Xq22.1 | gain | - | - | de novo CNVs; | Brandler WM, 2018 |
AutCNV0005940 | X | Xq28 | loss | - | - | de novo CNVs; | Brandler WM, 2018 |
AutCNV0005941 | 1 | 1q21.1-q21.2 | gain | - | - | Brandler WM, 2018 | |
AutCNV0005942 | 7 | 7q11.23 | gain | - | - | de novo CNVs; | Brandler WM, 2018 |
AutCNV0005943 | 15 | 15q11.2 | loss | - | - | Brandler WM, 2018 | |
AutCNV0005944 | 15 | 15q11.2-q13.1 | gain | - | - | de novo CNVs; | Brandler WM, 2018 |
AutCNV0005945 | 15 | 15q11.2-q13.1 | - | - | - | Brandler WM, 2018 | |
AutCNV0005946 | 15 | 15q13.1-q13.3 | loss | - | - | de novo CNVs; | Brandler WM, 2018 |
AutCNV0005947 | 16 | 16p13.11 | loss | - | - | de novo CNVs; | Brandler WM, 2018 |
AutCNV0005948 | 16 | 16p13.11 | gain | - | - | Brandler WM, 2018 | |
AutCNV0005949 | 16 | 16p13.11-p12.3 | gain | - | - | Brandler WM, 2018 | |
AutCNV0005950 | 16 | 16p11.2 | loss | - | - | de novo CNVs; | Brandler WM, 2018 |
AutCNV0005951 | 22 | 22q13.33 | loss | - | - | de novo CNVs; | Brandler WM, 2018 |